ROGERS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ROGERS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $222.94M | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | $226.86M | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | $214.68M | Feb 21, 2019 |
| FY2018 | Mar 31, 2018 | $214.61M | Feb 21, 2019 |
| FY2018 | Dec 31, 2017 | $209.01M | Feb 21, 2019 |
| FY2018 | Sep 30, 2017 | $206.78M | Feb 21, 2019 |
| FY2018 | Jun 30, 2017 | $201.42M | Feb 21, 2019 |
| FY2018 | Mar 31, 2017 | $203.83M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $656.31M | Feb 21, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $810.80M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $830.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $908.40M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $971.20M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $932.90M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $210.67M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $201.94M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $191.16M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $198.81M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $193.77M | Feb 19, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $209.01M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $206.78M | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $201.42M | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $203.83M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $173.00M | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $165.26M | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $157.49M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $160.57M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $152.93M | Feb 21, 2017 |
| FY2016 | Sep 30, 2015 | $160.37M | Feb 21, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $256.80M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $277.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $307.10M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $321.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $349.10M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $80.70M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $75.52M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $69.97M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $65.63M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $64.20M | Feb 19, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($61.80M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $26.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $56.60M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $116.60M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $108.10M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $49.99M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $47.32M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $87.65M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $80.46M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $48.28M | Feb 21, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($45.00M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $24.90M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $85.30M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $144.40M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $117.20M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $67.33M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $110.48M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $112.71M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $129.14M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $80.90M | Feb 21, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $34.60M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $35.70M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $35.20M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $29.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $29.32M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $31.69M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $33.08M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $29.55M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $28.58M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.60M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $193.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $202.30M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $218.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $193.10M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $182.28M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $168.68M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $164.05M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $161.65M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $139.27M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $101.20M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $127.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $131.40M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $129.50M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $124.40M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $165.06M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $161.32M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $66.82M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $138.98M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $116.97M | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $56.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $57.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $116.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $71.10M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $40.39M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $51.60M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $47.12M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $27.22M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $18.14M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.43B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.52B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.65B | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $1.60B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.26B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.27B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $1.28B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.13B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.06B | Feb 21, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.25B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.26B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.17B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.12B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.02B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $933.90M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $848.32M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $766.57M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $635.79M | Feb 21, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $303.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $357.60M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $359.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $352.40M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $370.19M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $270.17M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $262.93M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $264.89M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $237.11M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $208.43M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.16B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.10B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $981.83M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $873.69M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $823.70M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $776.40M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $684.54M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $591.35M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $197.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $159.80M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $131.70M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $235.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $232.30M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $191.79M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $166.85M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $167.74M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $181.16M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $227.77M | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $98.00M | Feb 20, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 4 | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | 4 | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 4 | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | 4 | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Feb 21, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.80M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 18.50M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 18.60M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 18.60M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 18.73M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 18.68M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 18.58M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 18.40M | Feb 21, 2020 |
| FY2017 | Dec 31, 2017 | 18.26M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | 18.02M | Feb 28, 2018 |